SCHEMBL7843040

SCHEMBL7843040

Cc1[nH]c(-c2ccc(S(C)(=O)=O)cc2)c(-c2ccc(F)cc2)c1CO

nearest known ligand 0.59

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 18/20 0.59
PTGS1 P23219 2/20 0.49
MAPK13 O15264 1/20 0.47
RAF1 P04049 1/20 0.47
MAPK9 P45984 1/20 0.47
MAPK12 P53778 1/20 0.47
MAPK11 Q15759 1/20 0.47
MAPK14 Q16539 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7852207 0.82 PTGS2 (0.51) PTGS2PTGS1
SCHEMBL8823417 0.82 PTGS2 (0.66) PTGS2PTGS1
SCHEMBL7855541 0.80 PTGS2 (0.51) PTGS2PTGS1
SCHEMBL7989345 0.79 PTGS2 (0.59) PTGS2PTGS1
SCHEMBL7853463 0.79 PTGS2 (0.50) PTGS2PTGS1
SCHEMBL7856241 0.79 PTGS2 (0.47) PTGS2PTGS1
SCHEMBL7857386 0.79 PTGS2 (0.47) PTGS2
SCHEMBL10738022 0.74 PTGS2 (0.78) PTGS2PTGS1MAPK11MAPK14
SCHEMBL10739840 0.74 PTGS2 (1.00) PTGS2PTGS1
SCHEMBL10733489 0.73 PTGS2 (1.00) PTGS2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1085845-A2 MULTIBINDING INHIBITORS OF CYCLOOXYGENASE-2 Advanced Medicine, Inc. (US) 2001-03-28 EP disclosed
EP-0989857-A4 NOVEL THERAPEUTIC AGENTS THAT MODULATE ENZYMATIC PROCESSES ADVANCED MEDICINE INC (US) 2001-01-17 EP disclosed
EP-0989857-A1 NOVEL THERAPEUTIC AGENTS THAT MODULATE ENZYMATIC PROCESSES Advanced Medicine, Inc. (US) 2000-04-05 EP disclosed
WO-1999063939-A2 MULTIBINDING INHIBITORS OF CYCLOOXYGENASE-2 ADVANCED MEDICINE, INC. (US) 1999-12-16 WO disclosed
WO-1999064037-A1 NOVEL THERAPEUTIC AGENTS THAT MODULATE ENZYMATIC PROCESSES ADVANCED MEDICINE, INC. (US) 1999-12-16 WO disclosed